Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin J Am Soc Nephrol. 2010 Aug; 5(8):1394-400.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
B-Lymphocytes
Boston
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Immunologic Factors
Immunosuppressive Agents
Male
Middle Aged
Recurrence
Retrospective Studies
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome
authors with profiles
John Lindsay Niles, M.D.
Eugene Park Rhee, M.D.